Testing fungal biomarkers for directing antifungal therapy for invasive fungal disease in patients with high-risk haematological malignancies in a University Teaching Hospital: a cost benefit analysis

被引：0
|
作者：
Perera, N. [1 ]
Lim, F. H. [1 ]
Saibudeen, A. [1 ]
Hodgson, K. [1 ]
机构：
[1] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
来源：
MYCOSES | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P126
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies
    Hoenigl, M.
    Zollner-Schwetz, I.
    Sill, H.
    Linkesch, W.
    Lass-Floerl, C.
    Schnedl, W. J.
    Krause, R.
    MYCOSES, 2011, 54 (05) : 454 - 459
  • [2] Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients
    Hammarstrom, Helena
    Aspelund, Anna Stjaerne
    Christensson, Bertil
    Heussel, Claus Peter
    Isaksson, Jenny
    Kondori, Nahid
    Larsson, Lennart
    Markowicz, Pawel
    Richter, Johan
    Wenneras, Christine
    Friman, Vanda
    MYCOSES, 2018, 61 (09) : 623 - 632
  • [3] Attributable Hospital Cost and Antifungal Treatment of Invasive Fungal Diseases in High-Risk Hematology Patients: an Economic Modeling Approach
    Ananda-Rajah, Michelle R.
    Cheng, Allen
    Morrissey, C. Orla
    Spelman, Tim
    Dooley, Michael
    Neville, A. Munro
    Slavin, Monica
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 1953 - 1960
  • [4] High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies
    Mori, Giovanni
    Diotallevi, Sara
    Farina, Francesca
    Lolatto, Riccardo
    Galli, Laura
    Chiurlo, Matteo
    Acerbis, Andrea
    Xue, Elisabetta
    Clerici, Daniela
    Mastaglio, Sara
    Stanghellini, Maria Teresa Lupo
    Ripa, Marco
    Corti, Consuelo
    Peccatori, Jacopo
    Puoti, Massimo
    Bernardi, Massimo
    Castagna, Antonella
    Ciceri, Fabio
    Greco, Raffaella
    Oltolini, Chiara
    MICROORGANISMS, 2024, 12 (01)
  • [5] Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification
    Chen, Lijin
    Luo, Luting
    Chen, Yanxin
    Wang, Yinzhou
    Li, Jing
    Zheng, Xiaoyun
    Yang, Ting
    Hu, Jianda
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [6] Performance, Correlation and Kinetic Profile of Circulating Serum Fungal Biomarkers of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies
    Siopi, Maria
    Karakatsanis, Stamatis
    Roumpakis, Christoforos
    Korantanis, Konstantinos
    Eldeik, Elina
    Sambatakou, Helen
    Sipsas, Nikolaos V.
    Tsirigotis, Panagiotis
    Pagoni, Maria
    Meletiadis, Joseph
    JOURNAL OF FUNGI, 2021, 7 (03)
  • [7] Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018-2022): An observational study
    Estagnasie, Camille
    Mohr, Catherine
    Kamus, Laure
    Zunic, Patricia
    Chirpaz, Emmanuel
    Moiton, Marie-Pierre
    Lagrange-Xelot, Marie
    MEDICAL MYCOLOGY, 2024, 62 (10)
  • [8] A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
    Biehl, Lena M.
    Vehreschild, J. Janne
    Liss, Blasius
    Franke, Bernd
    Markiefka, Birgid
    Persigehl, Thorsten
    Buecker, Vanessa
    Wisplinghoff, Hilmar
    Scheid, Christof
    Cornely, Oliver A.
    Vehreschild, Maria J. G. T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2634 - 2641
  • [9] Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience
    Garcia-Robles, A. A.
    Carreno-Sanchez, S.
    Fuentes-Socorro, C.
    Torres-Guerola, B.
    Garcia-Williams, S.
    Poveda-Andres, J. L.
    Fernandez-Navarro, J. M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S352 - S353
  • [10] Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease
    Bochennek, K.
    Balan, A.
    Mueller-Scholden, L.
    Becker, M.
    Farowski, F.
    Mueller, C.
    Groll, A. H.
    Lehrnbecher, T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) : 1527 - 1530
12345